Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry.
Rapetto C, Leoncini M, Cerrato E, Regazzoli D, Cortese B, Rossi A, Fetiveau R, Geraci S, De Angelis MC, Tespili M, Iannaccone M, Centola A, Durante A, De Carlo M, De Caterina A, Ribichini F, Favaretto E, Testa L, Pirisi R, Varbella F, Nicolini E, di Palma G, Loi B, Poli A, Caramanno G, Varricchio A, Garbo R, Cuculo A, Petronio AS, Berti S, Bollati M, Spedicato L, De Candia G, Piva T, Quadri G, Colombo A, Ielasi A. Rapetto C, et al. Among authors: piva t. Cardiovasc Revasc Med. 2021 Sep;30:1-8. doi: 10.1016/j.carrev.2020.09.036. Epub 2020 Oct 1. Cardiovasc Revasc Med. 2021. PMID: 33077393
Change in Peak Oxygen Uptake Predicted by the Moderate 1-km Treadmill Walking Test After Walking Training in Outpatients With Cardiovascular Disease.
Raisi A, Bernardi E, Myers J, Piva T, Zerbini V, Masotti S, Menegatti E, Caruso L, Mazzoni G, Grazzi G, Mandini S. Raisi A, et al. Among authors: piva t. J Cardiopulm Rehabil Prev. 2024 Mar 1;44(2):131-136. doi: 10.1097/HCR.0000000000000812. Epub 2023 Aug 25. J Cardiopulm Rehabil Prev. 2024. PMID: 37616588
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.
Ribichini F, Ansalone G, Bartorelli A, Beqaraj F, Berni A, Colangelo S, D'Amico M, Della Rovere F, Fiscella A, Gabrielli G, Indolfi C, La Vecchia L, Loschiavo P, Marinoni G, Marzocchi A, Milazzo D, Romano M, Sangiorgio P, Sheiban I, Tamburino C, Tuccillo B, Villani R, Cappi B, Quijada MJ, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69. J Cardiovasc Med (Hagerstown). 2010. PMID: 20090550 Clinical Trial.
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18. JACC Cardiovasc Interv. 2013. PMID: 24055444 Free article. Clinical Trial.
Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.
Navarese EP, Frediani L, Kandzari DE, Caiazzo G, Cenname AM, Cortese B, Piva T, Muçaj A, Tumscitz C, Paparoni F, Larosa C, Bisceglia T, Menozzi M, Gurbel PA, Kubica J. Navarese EP, et al. Among authors: piva t. Catheter Cardiovasc Interv. 2021 Mar;97(4):602-611. doi: 10.1002/ccd.29113. Epub 2020 Jul 17. Catheter Cardiovasc Interv. 2021. PMID: 32678493
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry.
Zimarino M, Barbanti M, Dangas GD, Testa L, Capodanno D, Stefanini GG, Radico F, Marchioni M, Amat-Santos I, Piva T, Saia F, Reimers B, De Innocentiis C, Picchi A, Toro A, Rodriguez-Gabella T, Nicolini E, Moretti C, Gallina S, Maddestra N, Bedogni F, Tamburino C. Zimarino M, et al. Among authors: piva t. Circ Cardiovasc Interv. 2020 Dec;13(12):e009026. doi: 10.1161/CIRCINTERVENTIONS.120.009026. Epub 2020 Dec 4. Circ Cardiovasc Interv. 2020. PMID: 33272037
Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.
Rodriguez-Gabella T, Zimarino M, Barbanti M, Testa L, Capodanno D, Stefanini GG, Radico F, Fabbiocchi F, Piva T, Saia F, Biancari F, Eskola M, Niemelä M, Airaksinen J, Valtola A, Raivio P, Reimers B, Picci A, Nicolini E, Olivares P, Moretti C, Maddestra N, Bedogni F, Gallina S, Tamburino C, Amat-Santos IJ. Rodriguez-Gabella T, et al. Among authors: piva t. Int J Cardiol. 2021 Jun 15;333:69-76. doi: 10.1016/j.ijcard.2021.02.066. Epub 2021 Mar 1. Int J Cardiol. 2021. PMID: 33662485
Clinical Impact of Revascularization Extent in Patients Undergoing Impella-Protected PCI Enrolled in a Nationwide Registry.
Aurigemma C, Burzotta F, Chieffo A, Briguori C, Piva T, De Marco F, Di Biasi M, Pagnotta P, Casu G, Garbo R, Trani C, Tarantini G; IMP-IT Investigators. Aurigemma C, et al. Among authors: piva t. JACC Cardiovasc Interv. 2021 Mar 22;14(6):717-719. doi: 10.1016/j.jcin.2021.01.017. JACC Cardiovasc Interv. 2021. PMID: 33736787 Free article. No abstract available.
133 results